The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis. Heckman, C. A., Holopainen, T., Wirzenius, M., Keskitalo, S., Jeltsch, M., Yla-Herttuala, S., Wedge, S. R., Jurgensmeier, J. M., & Alitalo, K. Cancer Research, 68(12):4754–4762, June, 2008. undefined JUN 15 2008 The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis 10.1158/0008-5472.CAN-07-5809 WOS:000256855700034
The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis [link]Paper  bibtex   
@article{heckman_tyrosine_2008,
	title = {The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis},
	volume = {68},
	url = {http://dx.doi.org/10.1158/0008-5472.CAN-07-5809},
	number = {12},
	journal = {Cancer Research},
	author = {Heckman, Caroline A. and Holopainen, Tanja and Wirzenius, Maria and Keskitalo, Salla and Jeltsch, Michael and Yla-Herttuala, Seppo and Wedge, Stephen R. and Jurgensmeier, Juliane M. and Alitalo, Kari},
	month = jun,
	year = {2008},
	note = {undefined
JUN 15 2008
The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis
10.1158/0008-5472.CAN-07-5809
WOS:000256855700034},
	pages = {4754--4762},
}

Downloads: 0